Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:azacitidine
|
| gptkbp:approvalYear |
2004
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L01BC07
|
| gptkbp:CASNumber |
320-67-2
|
| gptkbp:chemicalFormula |
C8H12N4O5
|
| gptkbp:form |
powder for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vidaza
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Celgene
|
| gptkbp:mechanismOfAction |
DNA methyltransferase inhibitor
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
subcutaneous
intravenous |
| gptkbp:sideEffect |
gptkb:anemia
nausea vomiting neutropenia thrombocytopenia |
| gptkbp:usedForTreatmentOf |
gptkb:acute_myeloid_leukemia
myelodysplastic syndromes |
| gptkbp:bfsParent |
gptkb:Celgene
|
| gptkbp:bfsLayer |
6
|